Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 9/20 | 0.53 |
| ▸ | MAOB | P27338 | 5/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.39 |
| ▸ | GCGR | P47871 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4651759 | 0.82 | FFAR4 (0.56) | FFAR4MAOBHRH3 | |
| SCHEMBL6430133 | 0.82 | FFAR4 (0.52) | FFAR4MAOBHRH3FFAR1 | |
| SCHEMBL4650030 | 0.79 | FFAR4 (0.55) | FFAR4MAOBHRH3 | |
| SCHEMBL4650715 | 0.79 | FFAR4 (0.60) | FFAR4MAOBHRH3FFAR1 | |
| SCHEMBL4936500 | 0.78 | FFAR4 (0.57) | FFAR4HRH3PPARA | |
| SCHEMBL4650820 | 0.77 | FFAR4 (0.52) | FFAR4MAOBHRH3 | |
| SCHEMBL4936414 | 0.75 | FFAR4 (0.53) | FFAR4MAOBHRH3PPARA | |
| SCHEMBL4928507 | 0.72 | FFAR4 (0.55) | FFAR4MAOBHRH3 | |
| SCHEMBL17028567 | 0.69 | FFAR4 (1.00) | FFAR4FFAR1 | |
| SCHEMBL5249481 | 0.69 | HRH3 (0.60) | MAOBHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6939990-B2 | Derivatives of dicarboxylic acid having pharmaceutical properties | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-06 | — | — | US | disclosed |
| US-20040110840-A1 | Novel derivatives of dicarboxylic acid having pharmaceutical properties | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110840-A1 | Novel derivatives of dicarboxylic acid having pharmaceutical properties | SDHA, GOT2, MDH2 | FFAR4 806/4885MAOB 2643/4885HRH3 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.